Pharmaceutical MedTech Analysis l Report Store l Pharma Intelligence

Bone Grafts and Substitutes

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global market for bone grafts and substitutes. Product segments covered by this report include allografts and synthetic bone substitutes, growth factors, and cellular bone matrices.

February 15, 2022

Find out more

Neuromodulation: Spinal Cord Stimulation Devices Market

$4,750.00

According to a recent CDC study, 20.1% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited life or work activities with similar numbers being reported in Europe. In 2021, the spinal cord stimulation (SCS) devices market was worth nearly $2.9 bn. Market drivers of the SCS devices market through 2026 will be driven by an aging population and an increase in selected conditions (eg back/leg pain, and a growing number of indications) that result in debilitating and unrelenting chronic pain.

February 22, 2022

Find out more

Drug Delivery: Injection Devices

$4,750.00

Despite its relative invasiveness and technological maturity, instrument-based injection of pharmaceutical preparations is commonly regarded as the most accurate, effective, reliable, and reproducible method of therapeutic drug and fluid delivery. In 2021, combined sales of the injection devices covered by this report totaled nearly $5.7bn.

March 15, 2022

Find out more

Prostate Cancer Diagnostics and Minimally Invasive Treatments Market

$4,750.00

This comprehensive medical market and technology report provides an overview and in-depth market analysis of selected next-generation prostate cancer diagnostics, biopsy, and minimally invasive treatments.

May 4, 2022

Find out more

Spinal Motion Preservation Devices Market

$4,750.00

Sales of spinal motion preservation devices totaled $1.7bn in 2019, with sales expected to climb at a CAGR of 2.0% during 2019-2024.

May 18, 2022

Find out more

Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

$4,750.00

This report provides an overview of primary neurological diseases/disorders treated with deep brain stimulation (DBS) and vagus nerve stimulation (VNS), as well as overviews of DBS and VNS neuromodulation technologies, competitors, sales, forecasts, and competitive and market analysis. Markets covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets.

May 26, 2022

Find out more

Drug Delivery: Transdermal Devices

$4,750.00

This chapter provides a discussion of the sales, competitors, drivers, and limiters of the transdermal drug delivery devices market in the areas of cardiovascular disease (CVD; eg angina pectoris and hypertension), neurological disorders (eg attention deficit hyperactivity disorder [ADHD], major depressive disorder [MDD], Alzheimer’s disease, and Parkinson’s disease), hormone replacement therapy (HRT; eg menopause and osteoporosis treatment), and pain management (eg fentanyl- and lidocaine-based chronic pain treatment). Markets covered by this analysis include the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets.

May 26, 2022

Find out more

2022 ASCO Weekend Update

$1,318.00

The 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO) is being held in Chicago from 3–7 June 2022.

June 5, 2022

Find out more

Interventional Neurology: Mechanical Thrombectomy Devices

$4,750.00

Mechanical thrombectomy (MT) is an emergency surgical technique used in eligible patients experiencing acute ischemic stroke (AIS) to remove a blood clot in the brain. In 2021, the combined global market for neuroendovascular MT devices was estimated at approximately $706m.

June 14, 2022

Find out more

Molecular Diagnostics

$4,750.00

Molecular diagnostics is being applied to an increasingly wide range of applications in infectious disease, oncology, and genetic disease diagnosis and screening, and to a number of emerging applications. The market for molecular diagnostics products totaled nearly $21bn in 2021. Following a projected downturn in 2022 and 2023 due to a decline in COVID-19 testing, the market is expected to return to growth in 2024. Drivers of the market will include adoption of new types of tests, expansion of target populations for molecular testing, and advances in the level of diagnostic testing services provided, particularly in developing countries.

June 28, 2022

Find out more

MedTech analysis

Bone Grafts and Substitutes

Neuromodulation: Spinal Cord Stimulation Devices Market

Drug Delivery: Injection Devices

Prostate Cancer Diagnostics and Minimally Invasive Treatments Market

Spinal Motion Preservation Devices Market

Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

Drug Delivery: Transdermal Devices

2022 ASCO Weekend Update

Interventional Neurology: Mechanical Thrombectomy Devices

Molecular Diagnostics